Domov › Adenokarcinom požiralnika › New York › New York City

Klinične študije za Adenokarcinom požiralnika v New York City, NY

18 študij za Adenokarcinom požiralnika išče udeležence na lokacijah v New York City in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Vključevanje udeležencevFaza 2/3

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Vključevanje udeležencevFaza 3

Manhattan Eye Ear and Throat Hospital, New York
NYP/Weill Cornell Medical Center, New York
Lenox Hill Hospital, New York

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05677490

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Vključevanje udeležencevFaza 2/3

Memorial Sloan Kettering Cancer Center, New York

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07221149

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Vključevanje udeležencevFaza 1/2

Memorial Sloan-Kettering Cancer Center, New York

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06324357

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Vključevanje udeležencevFaza 2/3

Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
Rockefeller Outpatient Pavilion (53rd Street), New York
Memorial Sloan Kettering Cancer Center - Main Campus, New York

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07392892

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Vključevanje udeležencevFaza 1

Columbia University Irving Medical Center, New York

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07277413

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas

Vključevanje udeležencevFaza 2

Weill Cornell Medicine - New York Presbyterian Hospital, New York

Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07546812

A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma

Vključevanje udeležencevFaza 1/2

Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07818018

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Vključevanje udeležencev

Columbia Universtiy, New York

Starost 18–89 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT05753748

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Vključevanje udeležencevFaza 3

Research Site, New York
Research Site, New York
Research Site, New York

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07431281

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Vključevanje udeležencevFaza 1/2

NYU Langone Health, New York
Icahn School of Medicine At Mount Sinai Prime, New York

Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT06330064

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Icahn School of Medicine at Mount Sinai, New York

Starost 18 in več · Vsi spoli · Posodobljeno 15. jul. 2026 · NCT06657144

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Vključevanje udeležencevFaza 1

North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
Columbia University Irving Medical Center, New York

Starost 18 in več · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT04389632